Amarin reported $0.14 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.





Eps Change Date
AbbVie USD 3.65 1 Jun/2026
Alnylam Pharmaceuticals USD 1.84 0.15 Jun/2026
Amarin USD 0.14 0.06 Dec/2025
AstraZeneca USD 2.63 0.05 Jun/2026
BioCryst Pharmaceuticals USD 0.3 0.87 Jun/2026
DBV Technologies USD -0.55 0.31 Mar/2026
GlaxoSmithKline GBP 0.51 0.08 Jun/2026
Halozyme Therapeutics USD 1.6 1.84 Mar/2026
Heron Therapeutics USD -0.02 0.02 Dec/2025
Ionis Pharmaceuticals USD -0.69 0.13 Jun/2026
Nektar Therapeutics USD -1.78 0.43 Mar/2026
Neurocrine Biosciences USD 2.85 0.91 Jun/2026
Novartis USD 2.41 0.42 Jun/2026